In a filing, Neurocrine Biosciences, Inc. revealed its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $37278.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Neurocrine Biosciences, Inc.’s filing revealed that its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $37278.0 on May
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Neurocrine Biosciences, Inc.’s recent filing unveils that its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $37278.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
